• Baba T & Schneewind O (1996) Target cell specificity of a bacteriocin molecule: a C-terminal signal directs lysostaphin to the cell wall of Staphylococcus aureus. EMBO J 15: 47894797.
  • Bateman A & Rawlings ND (2003) The CHAP domain: a large family of amidases including GSP amidase and peptidoglycan hydrolases. Trends Biochem Sci 28: 234237.
  • Becker SC, Foster-Frey J, Stodola AJ, Anacker D & Donovan DM (2009a) Differentially conserved staphylococcal SH3b_5 cell wall binding domains confer increased staphylolytic and streptolytic activity to a streptococcal prophage endolysin domain. Gene 443: 3241.
  • Becker SC, Dong S, Baker JR, Foster-Frey J, Pritchard DG & Donovan DM (2009b) LysK CHAP endopeptidase domain is required for lysis of live staphylococcal cells. FEMS Microbiol Lett 294: 5260.
  • Croux C, Ronda C, Lopez R & Garcia JL (1993) Interchange of functional domains switches enzyme specificity: construction of a chimeric pneumococcal-clostridial cell wall lytic enzyme. Mol Microbiol 9: 10191025.
  • Daniel A, Euler C, Collin M, Chahales P, Gorelick KJ & Fischetti VA (2010) Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 54: 16031612.
  • De Lencastre H, Oliveira D & Tomasz A (2007) Antibiotic resistant Staphylococcus aureus: a paradigm of adaptive power. Curr Opin Microbiol 10: 428435.
  • Diaz E, Lopez R & Garcia JL (1990) Chimeric phage-bacterial enzymes: a clue to the modular evolution of genes. P Natl Acad Sci USA 87: 81258129.
  • Diaz E, Lopez R & Garcia JL (1991) Chimeric pneumococcal cell wall lytic enzymes reveal important physiological and evolutionary traits. J Biol Chem 266: 54645471.
  • Donovan DM, Dong S, Garrett W, Rousseau GM, Moineau S & Pritchard DG (2006) Peptidoglycan hydrolase fusions maintain their parental specificities. Appl Environ Microbiol 72: 29882996.
  • Donovan DM, Becker SC, Dong S, Baker JR, Foster-Frey J & Pritchard DG (2009) Peptidoglycan hydrolase enzyme fusions for treating multi-drug resistant pathogens. Biotech Int 21: 610.
  • Fischetti VA (2005) Bacteriophage lytic enzymes: novel anti-infectives. Trends Microbiol 13: 491496.
  • Grundling A & Schneewind O (2006) Cross-linked peptidoglycan mediates lysostaphin binding to the cell wall envelope of Staphylococcus aureus. J Bacteriol 188: 24632472.
  • Horgan M, O'Flynn G, Garry J, Cooney J, Coffey A, Fitzgerald GF, Ross RP & McAuliffe O (2009) Phage lysin LysK can be truncated to its CHAP domain and retain lytic activity against live antibiotic-resistant staphylococci. Appl Environ Microbiol 75: 872874.
  • Jones RN, Barry AL, Gavan TL & Washington JA II (1985) Susceptibility tests: microdilution and macrodilution broth procedures. Manual of Clinical Microbiology (Balows A, Hausler JWJ & Shadomy HJ, eds), pp. 972977. American Society for Microbiology, Washington, DC.
  • Loessner MJ (2005) Bacteriophage endolysins–current state of research and applications. Curr Opin Microbiol 8: 480487.
  • Loessner MJ, Gaeng S & Scherer S (1999) Evidence for a holin-like protein gene fully embedded out of frame in the endolysin gene of Staphylococcus aureus bacteriophage 187. J Bacteriol 181: 44524460.
  • Loessner MJ, Kramer K, Ebel F & Scherer S (2002) C-terminal domains of Listeria monocytogenes bacteriophage murein hydrolases determine specific recognition and high-affinity binding to bacterial cell wall carbohydrates. Mol Microbiol 44: 335349.
  • Lopez R, Garcia E, Garcia P & Garcia JL (1997) The pneumococcal cell wall degrading enzymes: a modular design to create new lysins? Microb Drug Resist 3: 199211.
  • Low LY, Yang C, Perego M, Osterman A & Liddington RC (2005) Structure and lytic activity of a Bacillus anthracis prophage endolysin. J Biol Chem 280: 3543335439.
  • Lu JZ, Fujiwara T, Komatsuzawa H, Sugai M & Sakon J (2006) Cell wall-targeting domain of glycylglycine endopeptidase distinguishes among peptidoglycan cross-bridges. J Biol Chem 281: 549558.
  • O'Flaherty S, Coffey A, Meaney W, Fitzgerald GF & Ross RP (2005) The recombinant phage lysin LysK has a broad spectrum of lytic activity against clinically relevant staphylococci, including methicillin-resistant Staphylococcus aureus. J Bacteriol 187: 71617164.
  • Rigden DJ, Jedrzejas MJ & Galperin MY (2003) Amidase domains from bacterial and phage autolysins define a family of gamma-D, l-glutamate-specific amidohydrolases. Trends Biochem Sci 28: 230234.
  • Sass P & Bierbaum G (2007) Lytic activity of recombinant bacteriophage {phi}11 and {phi}12 endolysins on whole cells and biofilms of Staphylococcus aureus. Appl Environ Microbiol 73: 347352.
  • Sheehan MM, Garcia JL, Lopez R & Garcia P (1996) Analysis of the catalytic domain of the lysin of the lactococcal bacteriophage Tuc 2009 by chimeric gene assembling. FEMS Microbiol Lett 140: 2328.